Partial agonists activate PPARgamma using a helix 12 independent mechanism
- PMID: 17937915
- DOI: 10.1016/j.str.2007.07.014
Partial agonists activate PPARgamma using a helix 12 independent mechanism
Abstract
Binding to helix 12 of the ligand-binding domain of PPARgamma is required for full agonist activity. Previously, the degree of stabilization of the activation function 2 (AF-2) surface was thought to correlate with the degree of agonism and transactivation. To examine this mechanism, we probed structural dynamics of PPARgamma with agonists that induced graded transcriptional responses. Here we present crystal structures and amide H/D exchange (HDX) kinetics for six of these complexes. Amide HDX revealed each ligand induced unique changes to the dynamics of the ligand-binding domain (LBD). Full agonists stabilized helix 12, whereas intermediate and partial agonists did not at all, and rather differentially stabilized other regions of the binding pocket. The gradient of PPARgamma transactivation cannot be accounted for solely through changes to the dynamics of AF-2. Thus, our understanding of allosteric signaling must be extended beyond the idea of a dynamic helix 12 acting as a molecular switch.
Similar articles
-
Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids.J Mol Biol. 2009 Jan 9;385(1):188-99. doi: 10.1016/j.jmb.2008.10.039. Epub 2008 Oct 19. J Mol Biol. 2009. PMID: 18977231
-
Hydrogen/deuterium-exchange (H/D-Ex) of PPARgamma LBD in the presence of various modulators.Protein Sci. 2006 Aug;15(8):1883-92. doi: 10.1110/ps.062103006. Epub 2006 Jul 5. Protein Sci. 2006. PMID: 16823031 Free PMC article.
-
Exploring the binding site structure of the PPAR gamma ligand-binding domain by computational solvent mapping.Biochemistry. 2005 Feb 1;44(4):1193-209. doi: 10.1021/bi048032c. Biochemistry. 2005. PMID: 15667213
-
Insights into Dynamic Mechanism of Ligand Binding to Peroxisome Proliferator-Activated Receptor γ toward Potential Pharmacological Applications.Biol Pharm Bull. 2021;44(9):1185-1195. doi: 10.1248/bpb.b21-00263. Biol Pharm Bull. 2021. PMID: 34471046 Review.
-
[Activation mechanism of PPARgamma by its endogenous ligands].Tanpakushitsu Kakusan Koso. 2005 Nov;50(13):1660-5. Tanpakushitsu Kakusan Koso. 2005. PMID: 16277244 Review. Japanese. No abstract available.
Cited by
-
Synthesis of a Coumarin-Based PPARγ Fluorescence Probe for Competitive Binding Assay.Int J Mol Sci. 2021 Apr 14;22(8):4034. doi: 10.3390/ijms22084034. Int J Mol Sci. 2021. PMID: 33919837 Free PMC article.
-
miR-30a targets gene networks that promote browning of human and mouse adipocytes.Am J Physiol Endocrinol Metab. 2020 Oct 1;319(4):E667-E677. doi: 10.1152/ajpendo.00045.2020. Epub 2020 Aug 17. Am J Physiol Endocrinol Metab. 2020. PMID: 32799658 Free PMC article.
-
In Vitro and In Vivo Characterizations of Chiglitazar, a Newly Identified PPAR Pan-Agonist.PPAR Res. 2012;2012:546548. doi: 10.1155/2012/546548. Epub 2012 Oct 22. PPAR Res. 2012. PMID: 23150725 Free PMC article.
-
Structural and Dynamical Insight into PPARγ Antagonism: In Silico Study of the Ligand-Receptor Interactions of Non-Covalent Antagonists.Int J Mol Sci. 2015 Jul 8;16(7):15405-24. doi: 10.3390/ijms160715405. Int J Mol Sci. 2015. PMID: 26184155 Free PMC article.
-
Definition of functionally and structurally distinct repressive states in the nuclear receptor PPARγ.Nat Commun. 2019 Dec 20;10(1):5825. doi: 10.1038/s41467-019-13768-0. Nat Commun. 2019. PMID: 31862968 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases